Literature DB >> 15733907

Increased late sodium current in myocytes from a canine heart failure model and from failing human heart.

Carmen R Valdivia1, William W Chu, Jielin Pu, Jason D Foell, Robert A Haworth, Mathew R Wolff, Timothy J Kamp, Jonathan C Makielski.   

Abstract

Electrophysiological remodeling of ion channels in heart failure causes action potential prolongation and plays a role in arrhythmia mechanism. The importance of down-regulation of potassium currents is well-known, but a role for Na current (I(Na)) in heart failure is less well established. We studied I(Na) in heart failure ventricular cells from a canine pacing model of heart failure and also from explanted failing human hearts. Peak I(Na) density was significantly decreased by 39% and 57% in the dog model and in human heart failure, respectively. The kinetics of peak I(Na) were not different in heart failure. Late I(Na) was measured 750 ms after the initial depolarization as the saxitoxin (STX)-sensitive current and also as the current remaining after contaminating currents were blocked. Late I(Na) as a percentage of the peak I(Na) was significantly increased in both conditions. In dogs, STX sensitive late I(Na) was 0.5 +/- 0.1% n = 16 cells from eight normal hearts and 3.4 +/- 1.4% n = 12 cells from seven failing hearts; in humans, it was 0.2 +/- 0.1% n = 4 cells from two normal hearts and 2.4 +/- 0.5% n = 10 cells from three human failing hearts (-40 mV). Quantitative measures of mRNA including RNase protection assays and real time quantitative PCR in the dog model showed no differences for different alpha subunit isoforms (NaV1.1, 1.3, 1.5) and for the beta1 and beta2 subunits. This suggests neither alpha subunit isoform switching nor altered beta subunit expression is a mechanism for increased late I(Na). We conclude that a peak I(Na) is decreased, and non-inactivating late I(Na) is increased in heart failure and this may contribute to action potential prolongation and the generation of arrhythmia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15733907     DOI: 10.1016/j.yjmcc.2004.12.012

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  156 in total

1.  Diseases caused by mutations in Nav1.5 interacting proteins.

Authors:  John W Kyle; Jonathan C Makielski
Journal:  Card Electrophysiol Clin       Date:  2014-12-01

2.  Differential regulation of EHD3 in human and mammalian heart failure.

Authors:  Hjalti Gudmundsson; Jerry Curran; Farshid Kashef; Jedidiah S Snyder; Sakima A Smith; Pedro Vargas-Pinto; Ingrid M Bonilla; Robert M Weiss; Mark E Anderson; Philip Binkley; Robert B Felder; Cynthia A Carnes; Hamid Band; Thomas J Hund; Peter J Mohler
Journal:  J Mol Cell Cardiol       Date:  2012-03-03       Impact factor: 5.000

3.  Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel.

Authors:  Man Liu; Hong Liu; Samuel C Dudley
Journal:  Circ Res       Date:  2010-08-19       Impact factor: 17.367

Review 4.  Electrical remodeling in dyssynchrony and resynchronization.

Authors:  Takeshi Aiba; Gordon Tomaselli
Journal:  J Cardiovasc Transl Res       Date:  2012-01-21       Impact factor: 4.132

5.  Na(+) channel I-II loop mediates parallel genetic and phosphorylation-dependent gating changes.

Authors:  Donald M Bers; Anthony W Herren
Journal:  Circulation       Date:  2012-10-23       Impact factor: 29.690

Review 6.  Current Management and Future Directions of Heart Failure With Preserved Ejection Fraction: a Contemporary Review.

Authors:  Chayakrit Krittanawong; Marrick L Kukin
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-20

7.  Overexpression of the Na+/K+ ATPase α2 but not α1 isoform attenuates pathological cardiac hypertrophy and remodeling.

Authors:  Robert N Correll; Petra Eder; Adam R Burr; Sanda Despa; Jennifer Davis; Donald M Bers; Jeffery D Molkentin
Journal:  Circ Res       Date:  2013-11-11       Impact factor: 17.367

Review 8.  Electrical remodeling in the failing heart.

Authors:  Takeshi Aiba; Gordon F Tomaselli
Journal:  Curr Opin Cardiol       Date:  2010-01       Impact factor: 2.161

9.  Novel pharmacological approaches for antiarrhythmic therapy.

Authors:  Ursula Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-01-15       Impact factor: 3.000

Review 10.  Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart.

Authors:  Albertas Undrovinas; Victor A Maltsev
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.